Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Allopurinol Improves Heart Function in African Americans With Resistant Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allopurinol to improve heart function in African Americans with resistant hypertension and heart failure with preserved ejecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Heart Failure Preserved Ejection Fraction, Resistant Hypertension | Phase 2 | Status: RECRUITING